Sisters for Heart Health: A Community Health Worker Initiative for Improving Heart Health
The goal of this hybrid Type 1 effectiveness-implementation trial is to test the extent to which a peer support and community resource navigation intervention improves psychological well-being, addresses non-biologic drivers of health (access to healthcare, supportive services, nutrition, housing stability, transportat
| Condition(s) | Occupational Stress, Gender Related Stress, Social Isolation, Hypertension, Pre Diabetes, Diabetes, Obesity |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this hybrid Type 1 effectiveness-implementation trial is to test the extent to which a peer support and community resource navigation intervention improves psychological well-being, addresses non-biologic drivers of health (access to healthcare, supportive services, nutrition, housing stability, transportation, chronic stress, social support), and thus reduces cardiometabolic risk among rural, low-income farmworker women aged 18-50 years. The main questions it aims to answer are: * If and to what extent does the intervention reduce stress, social isolation, and psychological distress by improving social support and access to needed resources? * If and to what extent does the intervention improve cardiometabolic health, measured by the American Heart Association's Life's Essenti |
| Who can participate | Inclusion Criteria: * Self-identified female employed as a farmworker; * Fluent in Spanish or English verbal literacy * Planning to be in the geographic area for a minimum of 6 months. Exclusion Criteria: * Cognitive or psychological impairment precluding informed consent and/or active participation in the study due to substance use, neurologic, or other disorder * Pregnant or breastfeeding. |
| Ages | 18 Years to 50 Years |
| Sex | Female |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Emory University |
| Locations | Ellenton, Georgia, United States |
| Start date | 2025-09-16 |
| NCT ID | NCT07111026 |
| Official listing | https://clinicaltrials.gov/study/NCT07111026 |